Sanofi vaccines division Sanofi Pasteur has partnered with Translate Bio for the development of a messenger RNA (mRNA) vaccine against Covid-19.
Translate Bio has already started the production of several mRNA constructs. The company will leverage its mRNA platform for the discovery, design and manufacture of SARS-CoV-2 vaccine candidates.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Sanofi will contribute via its vaccine expertise and external research networks support. The aim is to progress vaccine candidates for further development.
